Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 110Carcinoma, Intraductal, Noninfiltrating 7Breast Carcinoma In Situ 6Neoplasms 4Neoplasm Metastasis 3Inflammatory Breast Neoplasms 3Carcinoma, Ductal, Breast 3Breast Neoplasms, Male 3Infertility 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Breast Cancer Female 2Sleep Wake Disorders 1Quality of Life 1Pulmonary Fibrosis 1Prostatic Neoplasms 1Primary Breast Cancer 1Polycystic Ovary Syndrome 1Paget's Disease, Mammary 1Ovarian Neoplasms 1Obesity 1Neoplasm Recurrence, Local 1Liver Neoplasms 1Hot Flashes 1Fatigue 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Breast Cancer Subjects 1

Interventions

Paclitaxel 79Carboplatin 64Bevacizumab 33liposomal doxorubicin 29Topotecan 28Gemcitabine 25Cisplatin 19olaparib 18Drug Therapy 12Doxorubicin 12Taxes 11niraparib 9Docetaxel 6CP protocol 6Trabectedin 5Hyperthermic Intraperitoneal Chemotherapy 5Etoposide 5Cyclophosphamide 51-dodecylpyridoxal 5rucaparib 4pembrolizumab 4avelumab 4atezolizumab 4Immunoglobulin G 4Ifosfamide 4Disulfides 4Dexamethasone 4Chemotherapy, Adjuvant 4trebananib 3fluzoparib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Ovarian Neoplasms × Tamoxifen × Clear all
NCT02728622 2016-04-05

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 3 Completed
241 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡